Australasian Gene and Cell Therapy Society | Science, technology & engineering

Australasian Gene and Cell Therapy Society

Add/Update information

Reviews

Tags

• Businesses
• Medical and health
• Education
• Science, technology & engineering
• Science
• technology & engineering

24.01.2022 The University of Queenslands potential COVID-19 vaccine is entering an important new phase of testing with the live coronavirus to determine how effectively it induces protection against coronavirus infection. http://tinyurl.com/vk2q8zl

22.01.2022 https://www.news-medical.net//Researchers-generate-accurat

22.01.2022 Congratulation to our very own Samantha Ginn and colleagues at the University of Sydney for winning this round of the best paper in gene and cell therapy! https://pubmed.ncbi.nlm.nih.gov/32039406/

21.01.2022 Bill Gates said it! Re-posting from #asgct #genetherapy

21.01.2022 Great source to keep yourselves updated during these challenging times on the latest research on Covid-19: https://www.nature.com/articles/d41591-020-00008-y

20.01.2022 Moving forward towards a cure for acute myeloid leukemia.

19.01.2022 Speaker: Hildegard Büning, Hannover Medical School Chair: Juan Bueren, CIEMAT/CIBERER, Madrid Submit your questions in the video comments box!

19.01.2022 Interested in learning more about AAV and gene therapy? Check out the live webinar organised by the Genetic Engineering & Biotechnology News (GEN), where GEN editors and guests discuss the state of gene therapy, the rise of AAV, and the safety issues that need to be addressed going forward: https://gen.omeclk.com/portal/public/ViewCommInBrowser.jsp

18.01.2022 Wishing everyone a happy new year 2021!!!

17.01.2022 Dear AGCTS members, This is a reminder that the January to June round for the "Best Gene Therapy paper" by an AGCTS member is open for submissions. The AGCTS Executive offers up to two $250 awards in each six-month period of a calendar year to the author of a gene therapy or RNA technology therapeutic publication. Either the first OR corresponding author member with a manuscript accepted for publication is eligible to apply (publication acceptance letter to be supplied if no...t already in press). Prizes are awarded to the applicant(s) of the top ranked manuscript(s). Only original research papers will be considered. Please forward your manuscript submissions in PDF format to the Secretary Samantha Ginn at [email protected] by the 30th June 2020 for consideration. We look forward to receiving your manuscripts!

17.01.2022 Another drug for DMD https://www.fda.gov//fda-approves-targeted-treatment-rare-

17.01.2022 First oral drug for SMA. https://www.gene.com//fda-approves-genentechs-evrysdi-risd

16.01.2022 First treatment for Progeria!!! https://globalgenes.org//fda-approves-first-treatment-for/

15.01.2022 Join us now for our Annual General Meeting! All members should have received an email with the log in details and agenda.

14.01.2022 We hope you had a good summer break and look forward to the 4th series of our e-School: Safety aspects of gene therapy and gene editing. Don't forget to join u...s live on YouTube tomorrow 2 September from 14:00 CEST for the first talk in this new series. Toni Cathomen, University of Freiburg will talk about Safety aspects of gene editing

14.01.2022 Precision medicine for rare disease!!! https://www.globenewswire.com//Praxis-Precision-Medicines-

14.01.2022 Abstracts available to read for those atrending the first ever virtual ASGCT 2020 meeting!

13.01.2022 We're excited that the ASGCT's 2020 Annual Meeting has not been cancelled and will take on a virtual format! "After careful consideration of the ongoing spread of COVID-19 overseas and in the United States, the American Society of Gene & Cell Therapy (ASGCT) Board of Directors has decided not to conduct ASGCTs 2020 Annual Meeting in Boston, Massachusetts scheduled for May 2020." More information on the link: https://annualmeeting.asgct.org/am20/registration/covid-19

12.01.2022 Interim results for Modernas mRNA-based vaccine for COVID-19 have been published in NEJM:

12.01.2022 For anyone interested in the latest COVID-19 research check out the ASGCT's COVID-19 virtual scientific symposium on September 15-16. Registration is complimentary and open now! https://www.asgct.org/events/covid-symposium

12.01.2022 "Intermittent distancing may be required into 2022 unless critical care capacity is increased substantially or a treatment or vaccine becomes available." Great study from Kissler and colleagues from the Harvard T.H. Chan School of Public Health on modelling the viral, environmental, and immunologic factors that could contribute to different pandemic and post-pandemic scenarios.

11.01.2022 Dear AGCTS members, Please be advised that the next Annual General Meeting of the AGCTS will be held via Zoom on Wednesday 3rd June 2020 at 2.00pm (EST). Details on how to join and an agenda will be included in a following email closer to the date. Business to be transacted at the AGM will include:... (a) Confirmation of the minutes from the 2019 AGM and special meeting (see attached) (b) To receive committee reports of the previous financial year If members would like to add any business to the agenda, please notify the Secretary by return E-mail at [email protected] by Friday 22rnd May 2020.

10.01.2022 One of our executive committee members's passion towards rare diseases.

09.01.2022 Do you have a project in gene and cell therapy that needs some funding? Check out the Career Development Award from ASGCT. Open to all nationalities but applicant and mentor need to be based in the US for the duration of the award. https://www.asgct.org//grants-aw/career-development-awards

09.01.2022 Forget your beauty sleep this week and instead catch up on some exciting gene and cell therapies research!

08.01.2022 Great effort from the Vandenberghe Lab at Mass Eye and Ear/Harvard Medical School to harness the power of AAV towards the development of a vaccine for Covid-19 #AAVCOVID

07.01.2022 Save the date for AGCTS meeting!!!

05.01.2022 New drug application for another DMD drug accepted by FDA. https://investorrelations.sarepta.com//sarepta-therapeutic

05.01.2022 Check out our new logo!!

03.01.2022 Re-posting from #asgct this great overview explaining the differences between treatment strategies #genetherapy #celltherapy #geneediting

03.01.2022 https://www.nature.com/articles/d41586-020-01906-4

03.01.2022 Combining gene therapy and antisense oligonucleotide technologies, researchers at University of San Diego, California (USCD) have found a relatively simple way to transform astrocytes into neurons to treat Parkison disease: https://www.nature.com/articles/s41586-020-2388-4

03.01.2022 **Meeting postponed due to Covid-19** We are currently looking into hosting this meeting in mid November. We'll keep you posted with any updates. Save the date for our National Gene Transfer Technologies Meeting later this year!

03.01.2022 Another promising gene therapy!! https://hemophilianewstoday.com//isth2020-flt180a-leads-t/

02.01.2022 https://www.shiftpharmaceuticals.com//fda-grants-orphan-d/

02.01.2022 The second exon skipping drug golodirsen increased dystrophin protein in DMD patients. https://n.neurology.org//2/03/04/WNL.0000000000009233.long

02.01.2022 The first clinical results from Sarepta’s peptide phosphorodiamidate morpholino oligomer (PPMO) show promising. https://investorrelations.sarepta.com//sarepta-therapeutic

01.01.2022 https://www.prnewswire.com//ionis-treatment-for-alexander-

01.01.2022 Great news towards a cure for Batten disease

01.01.2022 https://www.fda.gov//orphan-products/rare-disease-day-2020

01.01.2022 Dear AGCTS members, Please note the date change which is now after the NHMRC Ideas grant final deadline. Please be advised that the next Annual General Meeting of the AGCTS will be held via Zoom on Friday 12th June 2020 at 2.00pm (EST). Details on how to join and an agenda will be emailed closer to the date.... Business to be transacted at the AGM will include: (a) Confirmation of the minutes from the 2019 AGM and special meeting (see attached) (b) To receive committee reports of the previous financial year If members would like to add any business to the agenda, please notify the Secretary by return E-mail at [email protected] by Friday 29th May 2020. Kind regards, Samantha (on behalf of the AGCTS Executive)